Moshe Rogosnitzky: pioneering cancer researcher, multi-disciplinary scientist and medical consultant
Moshe Rogosnitzky is a research scientist, innovator and inventor of major medical breakthroughs, and consultant to oncology specialists, patients and companies.
His extraordinary career has spanned multiple disciplines and has produced ground-breaking cancer and auto-immune disease treatments.
His belief that medicine and science should deliver rapid and tangible benefits to the patient has been the driving force behind all his accomplishments.
Be the first to know about my latest discoveries and activities
- Clinical trials (1)
- Conflict of Interest (1)
- Cureiosity® (1)
- Curiosity (1)
- Drug Repurposing (1)
- Gadolinium (1)
- Good Doctors (2)
- Magnetic Resonance Imaging (1)
- MRI (1)
- MRI scans (1)
- Off-label (1)
- Outside-the-box thinking (1)
- Patience (1)
- Patients (1)
- Placebo (1)
- Serendipity (1)
- Time Management (1)
- Uncategorized (3)
“Nothing in life is to be feared, it is only to be understood. Now is the time to understand more so that we may fear less.” –Marie Curie On March 4, I was scheduled to deliver a lecture at Tel Aviv University on the topic of drug repurposing. Instead, I was quarantined at home following …Read More …
This past Thursday, February 28th, I was honored to stand before some of the world’s greatest thinkers, industry game-changers, and leaders of innovation in the US Army, Navy, NASA, Ford, General Mills, and Harvard Medical School to deliver a lecture at the MIT Innovation Lab at the Sloan School of Management. Chaired by renowned economist …Read More …
Gd is the chemical symbol for gadolinium, a rare metal that is commonly used during magnetic resonance imaging (MRI) scans and is approved by the FDA. Thirty million MRI scans are conducted each year in the US alone, and many more worldwide. One third of these scans utilize gadolinium-based contrast agents to “light up” suspicious …Read More …
I recently flew from Vienna to New York on Austrian Airlines. As sometimes happens after landing, a number of passengers were impatient and stood before the plane arrived at the gate. I was impressed with how the chief flight attendant handled the situation. He grabbed the microphone and announced, “Ladies and gentlemen, in the history …Read More …
Serendipity is understood to mean the fortuitous discovery of that which we didn’t set out to seek. Usually, we think of science as following well-defined logical processes and that new discoveries grow out of those established paradigms. However, some of the most important medical discoveries in the past century were made serendipitously.Famous serendipitous discoveriesThe first …Read More …
In light of the advances in knowledge and education wouldn’t we expect modern, sophisticated human beings to be more discerning and less naive than their forebears? Wouldn’t it be logical to assume that we are less susceptible to the charms of the snake-oil salesman than people were 100 years ago, when the majority of the …Read More …
Some years ago, while helping a young man suffering from treatment-resistant colitis (inflammation of the large intestine) I came across several safe, little-known treatments using existing approved drugs that originally had been developed for other purposes. The patient’s gastroenterologist wasn’t open to the thought of using anything outside “protocol” despite the fact that the effectiveness …Read More …
“Necessity may be the mother of invention, but curiosity is the mother of discovery.” –Charles Handy. “I have no special talent. I am only passionately curious.” –Albert Einstein. Medicine faces a great crisis—this is undeniable. The constantly increasing cost of medical care as a ratio of GDP is a global phenomenon. The claim that an …Read More …
Some years ago I visited a researcher at one of the leading universities on the US East Coast. This researcher, a distinguished professor with many awards, discovered a treatment that was helping thousands of patients suffering from chronic disease. Someone chose to publicize his phone number on a popular website and he was receiving calls …Read More …
Click on the icons below to learn about some of Moshe’s endeavors
Founder and Director, Adjuvant Medical Solutions
A personalized medicine consultancy employing unique methodologies to expand treatment options for sufferers of cancer and chronic disease. Established in 1999, Adjuvant Medical Solutions was one of the first pioneers in the area of personalized medicine consultancy.
Founder and Director, Center for Drug Rediscovery
World’s first academic drug repurposing center at Ariel University. Utilizes academic expertise and resources to expedite the development new cures using existing drugs benefiting patients worldwide.
Project Founder and Research Director, Cureiosity
Precision Medicine and Drug Rediscovery online knowledge base. A collaborative effort between MedInsight Research Institute and Ariel University’s Center for Drug Repurposing. Enables patients to benefit from real-life target-driven drug repurposing opportunities.
Founder, Dipyridamole Eye Drops
A non-profit project of MedInsight Research Institute established in 2015 to freely disseminate information about the new eye-disorder repurposed drug, “dipyridamole”.
Founder and Director, Drug Rediscovery
Private Technology-Transfer Office of Center for Drug Repurposing at Ariel University.
Founder and Director, LDN Doctor
An online telemedicine consultancy service for US patients in need of treatment with Low Dose Naltrexone (LDN). Founded in 2015.
A non-profit project of MedInsight Research Institute established in 2010. The first original resource for comprehensive scientific information about Low Dose Naltrexone (LDN), and the largest international directory of LDN prescribing doctors.
Co-Founder, Executive Director and Research Director, MedInsight
MedInsight Research Institute. A US/UK based non profit organization (501(c)(3)) established in 2006 researching and indexing all available off-label (repurposed) treatments for cancer and chronic diseases. MedInsight employs a graph-oriented database to drive innovation in the field of drug repurposing.
Founder and Executive Director, We Fund The Cure
Crowd-funding non-profit organization (501(c)(3)) funding discovery of new cures using existing drugs